Live Webinar Update on ongoing and future breast cancer trials
Wednesday, June 17th, 2020 7 p.m. CET MODERATION Isabel [...]
Webminar AECIMA “Reconstrucción prepectoral con prótesis”
"Reconstrucción prepectoral con prótesis" Día 18 de junio 20 [...]
Attitude and practices towards breast cancer management during covid19 pandemia
El objetivo de esta encuesta es explorar el impacto de la pandemia de Covid-19 en el manejo del cáncer de mama entre las unidades internacionales de cáncer de mama.
Certificación Europea de Cirujanos de Mama
Certificación Europea de Cirujanos de Mama
A todas nuestras queridas pacientes
Sabemos que esta epidemia del coronavirus Covid19 lo ha eclipsado absolutamente todo, incluso tu lucha contra el cáncer de mama
Diagnóstico y tratamiento quirúrgico de las pacientes con cáncer de mama durante la pandemia de COVID-19
Diagnóstico y tratamiento quirúrgico de las pacientes con cáncer de mama durante la pandemia COVID-19
FDA Allows Continued Sales of Textured Breast Implants
The United States Food and Drug Administration (FDA) has announced that it will allow continued sales of textured breast implants, which regulators in other nations have banned or restricted because of concerns about a rare cancer, breast implant- associated anaplastic large cell lymphoma (BIA-ALCL).
Impact of the Society of Surgical Oncology–American Society for Radiation Oncology Margin Guidelines on Breast-Conserving Surgery and Mastectomy Trends
In 2014, SSO/ASTRO guidelines defined negative margin for stage I and II breast cancer as “no tumor on ink”. We hypothesized that repeat surgery rates have decreased since guideline introduction and would be associated with changes in overall surgical trends.
Jornada enfermería en Cirugía de Mama – VIII Congreso AECIMA
El VIII Congreso de AECIMA contará con una Jornada de enfermería en cirugía de mama que se celebrará el día 16 de mayo de 2019 en el Ilustre Colegio de Médicos de Valencia.
Breast Implant ALCL: Excellent
The standard approach to treatment of breast implant–associated anaplastic large-cell lymphoma (BIA-ALCL) is complete oncologic resection, as per the 2019 National Comprehensive Cancer Network (NCCN) consensus guidelines.